Ethic Inc’s Ingevity NGVT Stock Holding History

Ethic Inc’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$332K	Buy	4,447 +1,430	+47%	+$103K	﹤0.01%	1086
2026 Q1	$215K	Buy	+3,017	New	+$206K	﹤0.01%	1141

Other funds holding NGVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Ethic Inc's NGVT Position: Q2 2026 in Review

Ethic Inc increased its Ingevity (NGVT) stake by 47% in Q2 2026, buying an estimated $103K and bringing the position to 4,447 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #1086.

Ethic Inc first reported a position in NGVT in Q1 2026 and has held it in 2 quarters since. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

Ethic Inc held 4,447 shares of Ingevity worth $332K as of Q2 2026.
Ethic Inc bought 1,430 Ingevity shares in Q2 2026, an estimated $103K.
Ingevity made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1086 holding.
Ethic Inc first reported a position in Ingevity in Q1 2026 and has held it in 2 quarters since.
315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.